|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Autonomic Nervous System Disease | |||||
| Healthy | |||||
| Hypertension | |||||
| Pheochromocytoma | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Autonomic Nervous System Diseases | |||||
| Nervous System Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms, Germ Cell and Embryonal | |||||
| Neoplasms, Nerve Tissue | |||||
| Neuroectodermal Tumors | |||||
| Neuroendocrine Tumors | |||||
| Paraganglioma | |||||
| Vascular Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||